Prosetta in drug discovery news

Written By John Flores

With new antivirals, monoclonal antibodies, and vaccines all in the works, researchers at the drug discovery company Prosetta Biosciences take a unique approach to rabies therapy: small molecules. Click here to see the full article

John Flores https://boxc.ar
Previous

Becerra announces Prosetta as semi-finalist
Next

Oxidized MIF is an Alzheimer’s drug target